Home
About Nanexa
Pharmashell®
Projects
Investors
Media
Contact
English
- Swedish

Annual General Meeting 2024

15 April, 2024 - Bolagsstämma

Annual General Meeting 2024, 15th of May 2024

Bilagor

Notice of AGM 15 May 2024 Nanexa AB

Proxy form, Nanexa AB

The boards proposal on amendment of the companys articles of association, Nanexa AB

Nanexa is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell® – the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. Nanexa develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.

CONTACT

Nanexa AB, Virdings Allé 2, SE-75450 Uppsala, Sweden
Phone: +46 (0) 18 100 300
E-mail: info@nanexa.se
Org nr. 556833-0285

Integritetspolicy
Integritetspolicy för aktieägare

English
Svenska